Abdominal wall neoplasm (DBCOND0010998)

Identifiers

Synonyms
Peritoneal Neoplasms / Peritoneal Neoplasm / Abdominal wall neoplasm NOS / Neoplasm of abdominal wall (disorder) / Peritoneal neoplasm NOS / Neoplasm of peritoneum (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05185947
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancertreatment2recruiting
NCT05617755
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients with Platinum Resistant Epithelial Ovarian CancerNo drug interventionstreatment1active_not_recruiting
NCT00262990
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancertreatment3completed
NCT01462890
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancertreatment3completed
NCT00517621
Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnairetreatment2completed
NCT00698451
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancerstreatment2completed
NCT00502177
Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With CisplatinNo drug interventionsNot AvailableNot Availablecompleted
NCT00103545
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Responseprevention1 / 2completed
NCT00382811
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancertreatment3completed
NCT01478685
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumorstreatment1completed
NCT00288275
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube CancerNo drug interventionsNot AvailableNot Availableterminated
NCT06351475
Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal ChemotherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03287375
Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -treatment2completed
NCT00318370
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapytreatment2completed
NCT03976999
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal CancersNo drug interventionsotherNot Availablerecruiting
NCT00445549
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancertreatment2terminated
NCT00516841
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancertreatment2terminated
NCT02786524
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00443196
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal AdenocarcinomasNo drug interventionstreatment2 / 3completed
NCT02082886
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT01932125
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancertreatment4active_not_recruiting
NCT00436657
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancertreatment1completed
NCT00666991
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancerstreatment1completed
NCT03150992
EDMONd - Elemental Diet in Bowel ObstructionNo drug interventionssupportive_careNot Availableunknown_status
NCT00074867
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancertreatment2completed
NCT00317772
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancertreatment1 / 2completed
NCT05194072
A Study of SGN-B7H4V in Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT01681368
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancertreatment2terminated
NCT00191646
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapytreatment3completed
NCT02658214
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumorstreatment1completed
NCT05257408
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancertreatment3active_not_recruiting
NCT03246321
PIPAC for Peritoneal Metastases of Colorectal CancerNo drug interventionstreatment2completed
NCT02638051
Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCTNo drug interventionstreatment2completed
NCT02758951
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastasestreatment2 / 3active_not_recruiting
NCT01384253
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapytreatment1completed
NCT00189345
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patientstreatment2completed
NCT01314105
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancertreatment1completed
NCT01846611
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancertreatment3completed
NCT02903771
Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.treatment1completed
NCT04111978
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)treatment3recruiting
NCT01697488
An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)No drug interventionsNot AvailableNot Availablecompleted
NCT02578888
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic MalignanciesNo drug interventionssupportive_careNot Availablecompleted
NCT00191607
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.treatment3completed
NCT00407407
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinomatreatment1terminated
NCT00001332
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal CarcinomatosisNo drug interventionstreatment1completed
NCT03038100
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancertreatment3completed
NCT00035100
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancertreatment2completed
NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancertreatment3completed
NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgerytreatment3active_not_recruiting
NCT00332696
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosistreatment2completed
NCT06223763
SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive SurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02231086
Adjuvant HIPEC in High Risk Colon Cancerprevention3completed
NCT00112086
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206treatment2completed
NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancertreatment1 / 2active_not_recruiting
NCT01225757
Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPECNo drug interventionsdiagnosticNot Availablewithdrawn
NCT03740165
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)treatment3active_not_recruiting
NCT05353582
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal MetastasesNo drug interventionstreatment2not_yet_recruiting
NCT02478476
DNA Single Nucleotide Polymorphisms as Predictors of ToxicityNo drug interventionsNot AvailableNot Availableunknown_status
NCT00183794
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinomatreatment2completed
NCT00086567
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT00063401
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancertreatment2completed
NCT00216372
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosistreatment3completed
NCT03593681
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of MalignancyNo drug interventionsNot AvailableNot Availablecompleted
NCT00352755
A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosistreatment2terminated
NCT00006155
SU5416 and Carboplatin to Treat Ovarian Cancertreatment1completed
NCT00004547
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapytreatment2completed
NCT00391118
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")treatment2completed
NCT00001569
Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosistreatment1completed